Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Aug;80(3):423-429.
doi: 10.18999/nagjms.80.3.423.

Primary hepatic carcinosarcoma with multimodal treatment

Affiliations
Case Reports

Primary hepatic carcinosarcoma with multimodal treatment

Daisuke Kurita et al. Nagoya J Med Sci. 2018 Aug.

Abstract

Hepatic carcinosarcoma (HCS) generally presents in advanced stages, demonstrates aggressive behavior, and has a poor prognosis. Other than curative primary resection, no effective treatment options exist. We present a case of resected HCS with four repeat resections for solitary lymph node recurrence followed by chemoradiotherapy with doxorubicin and ifosfamide. A 67-year-old Japanese man was admitted to our hospital for evaluation of an asymptomatic hepatic tumor. The patient underwent right hepatectomy with a presumptive preoperative diagnosis of atypical hepatocellular carcinoma. Based on histopathological and immunohistochemical findings, the tumor was diagnosed as HCS containing osteosarcoma and chondrosarcoma components. After the initial surgery, the patient underwent four additional resections for solitary lymph node HCS recurrence, and then underwent chemoradiotherapy with doxorubicin and ifosfamide for an unresectable lymph node recurrence. Chemotherapy was stopped after two cycles because of severe adverse events, although chemoradiotherapy markedly reduced the size of the lymph node recurrence and provided a progression-free survival of 12 months. Thirty-seven months after the initial surgery, the patient died of cardiac invasion of multiple mediastinal lymph node metastases. The clinical course outlined in this case report suggests that chemoradiotherapy with doxorubicin and ifosfamide for metastatic HCS may prolong survival in patients with unresectable lesions.

Keywords: chemoradiotherapy; doxorubicin; hepatic carcinosarcoma; ifosfamide.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A) Dynamic CT revealed a heterogenous low-density tumor in the posterior hepatic segments with rim enhancement during the portal phase (arrowheads). (B) Tumor thrombus in the right posterior portal vein was also observed (arrows).
Fig. 2
Fig. 2
(A) The cut surface of the resected specimen showed a yellowish-gray solid tumor. (B) The tumor contained elements of HCC (red), adenocarcinoma (orange), spindle-shaped sarcoma (blue), osteosarcoma and chondrosarcoma (gray), transitional zone (green), and necrosis (black).
Fig. 3
Fig. 3
Hematoxylin-eosin stain (× 20) of the tumor showed the following: (A) spindle-shaped sarcoma; (B) osteosarcoma; (C) chondrosarcoma; (D) moderately differentiated clear cell HCC; (E) poorly differentiated adenocarcinoma; (F) transitional zone composed of atypical epithelial and sarcomatous cells; (G) lymph node metastasis composed of spindle-shaped sarcoma.
Fig. 4
Fig. 4
(A) CT revealed an irregular-shaped tumor in the left supraclavicular region with infiltration of the internal carotid artery. (B) Chemoradiotherapy markedly reduced the size of the lymph node recurrence.

Similar articles

Cited by

References

    1. Tazawa H, Itamoto T, Oshita A, Kobayashi T, Amano H, Tashiro H, et al. Hepatic carcinosarcoma with heterogeneous carcinomatous and sarcomatous elements: report of a case and review of the literature. Clin J Gastroenterol, 2010; 3: 97–103. - PubMed
    1. Zhou YM, Sui CJ, Li B, Xu F, Kan T, Yang JM. Results of en bloc resection for hepatocellular carcinoma extending to adjacent organs. Can J Surg, 2012; 55: 222–226. - PMC - PubMed
    1. Namani D, Mitra N, Guo M, Lin L. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol, 2008; 111: 82–88. - PubMed
    1. Garg G, Shah JP, Kumar S, Bryant CS, Munkarah A, Morris RT. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes. Int J Gynecol Cancer, 2010; 20: 888–894. - PubMed
    1. Wright JL, Black PC, Brown GA, Porter MP, Kamat AM, Dinney CP, et al. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. J Urol, 2007; 178: 2302–2306. - PubMed

Publication types

LinkOut - more resources